Author:
Song Qi,Jiang Meiling,Pan Xinrong,Zhou Guanyue,Zhang Xiaomeng
Reference27 articles.
1. The role of interleukin-2 during homeostasis and activation of the immune system;Boyman;Nature Reviews Immunology,2012
2. Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells;Dovedi;Cancer Discovery,2021
3. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors;Gros;Journal of Clinical Investigation,2014
4. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial;Hodi;The Lancet Oncology,2016
5. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial;Hodi;The Lancet Oncology,2018